109 related articles for article (PubMed ID: 21331804)
21. Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma: A Prospective, Randomized Controlled Clinical Trial.
Wu X; Li B; Qiu J; Shen J; Zheng Y; Li Q; Liao Y; He W; Zou R; Yuan Y
J Clin Gastroenterol; 2015 Jul; 49(6):520-8. PubMed ID: 25564411
[TBL] [Abstract][Full Text] [Related]
22. [Surgical Resection for Mediastinal Lymph Node Metastasis of Combined Hepatocellular and Cholangiocarcinoma--A Case Report].
Yoshida M; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Okamura D; Suzuki D; Sakai N; Kagawa S; Nojima H; Miyazaki M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1857-9. PubMed ID: 26805196
[TBL] [Abstract][Full Text] [Related]
23. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
24. Metachronous solitary mediastinal lymph node metastases of hepatocellular carcinoma treated by video-assisted thoracic surgery twice: Report of a case.
Taniguchi M; Hyodo M; Tezuka K; Shinohara S; Hayashi H; Inoue Y; Satoh H; Tsukahara M; Lefor AK; Okada M; Yasuda Y
Asian J Endosc Surg; 2018 Feb; 11(1):64-67. PubMed ID: 28856831
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas.
Nagano Y; Shimada H; Ueda M; Matsuo K; Tanaka K; Endo I; Kunisaki C; Togo S
ANZ J Surg; 2009 Oct; 79(10):729-33. PubMed ID: 19878169
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.
Lemekhova A; Hornuss D; Polychronidis G; Mayer P; Rupp C; Longerich T; Weiss KH; Büchler M; Mehrabi A; Hoffmann K
World J Surg Oncol; 2020 May; 18(1):93. PubMed ID: 32397993
[TBL] [Abstract][Full Text] [Related]
27. Outcome of patients with fibrolamellar hepatocellular carcinoma.
Stipa F; Yoon SS; Liau KH; Fong Y; Jarnagin WR; D'Angelica M; Abou-Alfa G; Blumgart LH; DeMatteo RP
Cancer; 2006 Mar; 106(6):1331-8. PubMed ID: 16475212
[TBL] [Abstract][Full Text] [Related]
28. Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma.
Fastrez M; Goffin F; Vergote I; Vandromme J; Petit P; Leunen K; Degueldre M
Acta Obstet Gynecol Scand; 2013 Aug; 92(8):895-901. PubMed ID: 23590725
[TBL] [Abstract][Full Text] [Related]
29. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
Bhaijee F; Locketz ML; Krige JE
S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
[TBL] [Abstract][Full Text] [Related]
30. Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study.
Bruins HM; Skinner EC; Dorin RP; Ahmadi H; Djaladat H; Miranda G; Cai J; Daneshmand S
Urol Oncol; 2014 Jan; 32(1):24.e13-9. PubMed ID: 23395238
[TBL] [Abstract][Full Text] [Related]
31. Role of right upper mediastinal lymph node metastasis in patients with esophageal squamous cell carcinoma after tri-incisional esophagectomies.
Hsu PK; Huang CS; Hsieh CC; Wu YC; Hsu WH
Surgery; 2014 Nov; 156(5):1269-77. PubMed ID: 24953277
[TBL] [Abstract][Full Text] [Related]
32. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
33. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
Shimozawa N; Hanazaki K
J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of patients with lymph node metastasis treated with radical prostatectomy and adjuvant androgen deprivation therapy in a Chinese population: results from a cohort study.
Qin X; Han C; Zhang H; Dai B; Zhu Y; Shen Y; Zhu Y; Shi G; Ye D
World J Surg Oncol; 2015 May; 13():172. PubMed ID: 25943443
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic liver resection for hepatocellular carcinoma in cirrhosis: long-term outcomes.
Belli G; Fantini C; Belli A; Limongelli P
Dig Surg; 2011; 28(2):134-40. PubMed ID: 21540599
[TBL] [Abstract][Full Text] [Related]
36. Surgical approach for extrahepatic metastasis of HCC in the abdominal cavity.
Sano T; Izuishi K; Takebayashi R; Akamoto S; Kakinoki K; Okano K; Masaki T; Suzuki Y
Hepatogastroenterology; 2011; 58(112):2067-70. PubMed ID: 22024077
[TBL] [Abstract][Full Text] [Related]
37. Safety and technical feasibility of percutaneous ablation for lymph node metastases of hepatocellular carcinoma.
Yuan Z; Xing A; Zheng J; Li W
Int J Hyperthermia; 2019 Jan; 36(1):160-168. PubMed ID: 30776925
[TBL] [Abstract][Full Text] [Related]
38. Liver transplantation for unresectable hepatocellular carcinoma in normal livers.
Mergental H; Adam R; Ericzon BG; Kalicinski P; Mühlbacher F; Höckerstedt K; Klempnauer JL; Friman S; Broelsch CE; Mantion G; Fernandez-Sellez C; van Hoek B; Fangmann J; Pirenne J; Muiesan P; Königsrainer A; Mirza DF; Lerut J; Detry O; Le Treut YP; Mazzaferro V; Löhe F; Berenguer M; Clavien PA; Rogiers X; Belghiti J; Kóbori L; Burra P; Wolf P; Schareck W; Pisarski P; Foss A; Filipponi F; Krawczyk M; Wolff M; Langrehr JM; Rolles K; Jamieson N; Hop WC; Porte RJ
J Hepatol; 2012 Aug; 57(2):297-305. PubMed ID: 22521348
[TBL] [Abstract][Full Text] [Related]
39. [Clinical characteristics and prognosis of three rare and poor-prognostic subtypes of primary liver carcinoma].
Li Z; Huang Z; Bi X; Yang L; Zhao J; Zhao H; Zhang Y; Cai J; Zheng X
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):207-11. PubMed ID: 24785282
[TBL] [Abstract][Full Text] [Related]
40. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
